#AgomAbTherapeutics, #SpyGlassPharma, and #Veradermics have all set the terms for their initial pubic offerings on the #Nasdaq, looking to raise somewhere between $150 million and $200 million.
Hashtag
#SpyGlassPharma
Advertisement · 728 × 90
0
0
0
0
Glimmers of a resurgence in #biotech #IPO activity in 2026 have continued with the news that two more companies – Belgium's #AgomAbTherapeutics and #SpyGlassPharma of the US – are sizing up #investorinterest.
pharmaphorum.com/news/agomab-...
0
0
0
0
More $$ Raises: #David $75M Series A; #SpyGlassPharma $75M Series D; #FlockFreight $60M Series E
Acquisitions: #AMD > #Brium; #Datasite > #Grata; #Genpact > #XponentlData; #IBM > #SeekAI; #Him&HersHealth > #Zava; #IntelligentTechnicalSolutions > #BlackBreach; #JohnDeere > #Sentera
0
1
0
0